FMR LLC

Average Profitability
6.37%
Insider Buys Quantity
6
Insider Buys Sum
$20.84M
Insider Sells Quantity
118
Insider Sells Sum
$177.8M

Insider Activity of FMR LLC

According to the SEC Form 4 filings, FMR LLC, being in a position of

  1. See Remark 1 at Beam Therapeutics Inc.,
    оver the last 12 months, has bought 0 shares, and sold 901565 shares for $27.55M,
    over all time since 2022-04-12, has bought 0 shares, and sold 941908 shares for $29.79M.

The largest purchase of all time was on 2015-10-13 and amounted to 670910 shares of Aclaris Therapeutics, Inc. for $7.38M.

The largest sale of all time was on 2024-02-14 and amounted to 900000 shares of Beam Therapeutics Inc. for $27.5M.

Biography of FMR LLC

No biography is available at this moment.

2024-02-14SaleBeam Therapeutics Inc.
BEAM
See Remark 1
900,000
1.2132%
$30.55$27.5M-19.94%
2024-02-13SaleBeam Therapeutics Inc.
BEAM
See Remark 1
1,565
0.0021%
$30.76$48,139-16.44%
2022-09-06SaleBeam Therapeutics Inc.
BEAM
551
0.0013%
$54.25$29,892-30.61%
2022-08-05SaleBeam Therapeutics Inc.
BEAM
See Remark 1
20,159
0.0538%
$60.50$1.22M-36.35%
2022-08-04SaleBeam Therapeutics Inc.
BEAM
167
0.0004%
$61.00$10,187-35.78%
2022-07-12SaleVerve Therapeutics, Inc.
VERV
226,000
0.376%
$21.13$4.78M-3.51%
2022-07-01SaleVerve Therapeutics, Inc.
VERV
77,550
0.1358%
$15.66$1.21M+37.59%
2022-06-30SaleVerve Therapeutics, Inc.
VERV
other
18,810
0.0327%
$15.21$286,100+40.18%
2022-06-29SaleVerve Therapeutics, Inc.
VERV
53,219
0.109%
$15.45$822,476+38.19%
2022-04-13SaleBeam Therapeutics Inc.
BEAM
See Remark 1
18,803
0.0418%
$50.39$947,557-15.2%
2022-04-12SaleBeam Therapeutics Inc.
BEAM
663
0.0015%
$50.75$33,647-12.5%
2022-03-09SaleVerve Therapeutics, Inc.
VERV
7,942
0.0164%
$29.01$230,397-23.13%
2022-02-09SaleVerve Therapeutics, Inc.
VERV
10 percent owner
26,380
0.0511%
$29.46$777,155-26.8%
2022-02-01SaleVerve Therapeutics, Inc.
VERV
10 percent owner
71,148
0.1467%
$29.04$2.07M-19.9%
2022-01-27SaleVerve Therapeutics, Inc.
VERV
10 percent owner
17,966
0.0408%
$29.28$526,061-12.42%
2022-01-26SaleVerve Therapeutics, Inc.
VERV
10 percent owner
299,706
0.65%
$31.23$9.36M-21.15%
2019-04-01PurchasePrecision BioSciences, Inc.
DTIL
100,000
0.1888%
$16.00$1.6M-35.24%
2018-04-03PurchaseCogent Biosciences, Inc.
COGT
94,052
0.1074%
$12.00$1.13M-3.49%
2016-10-26SaleAclaris Therapeutics, Inc.
ACRS
10 percent owner
7,500
0.032%
$21.94$164,519+23.37%
2016-08-08SaleCoherus BioSciences, Inc.
CHRS
200,000
0.4574%
$29.86$5.97M-16.61%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.